First-in-Class Inhibitor Designated Orphan Drug for Spinal Muscular Atrophy
By inhibiting the activation of myostatin, SRK-015 may promote a clinically meaningful increase in muscle mass and strength.
All articles by Da Hee Han
Wearable System Provides 24-Hour Ambulatory GI Monitoring
The wearable system was found to work as well as more invasive methods.
Bio-Identical Combination Therapy Approved for Menopausal Vasomotor Symptoms
The target Prescription Drug User Fee Act date is October 2018.
Novel Urinalysis Tracks Cardiovascular Medication Adherence
A first-of-its-kind urinalysis may help physicians track patient adherence to cardiovascular medication.
Increased Flu Activity Anticipated for Several More Weeks, Per CDC
The CDC continues to recommend flu vaccination at this time.
FDA: Kratom Analysis Identifies Structural Similarities to Opioid Analgesics
To date, 44 deaths have been associated with the use of kratom.
Novel Tool Utilizing UV Light May Combat Spread of Influenza
Unlike broad-spectrum UVC light, far-UVC light has not been linked to skin cancer or cataracts.
ACIP Releases 2018 Child, Adolescent Immunization Schedule
Several updates have been made to the 2017 immunization schedule, including revised recommendations for poliovirus, influenza, and MMR vaccines.
Immunization Update: 2018 Recommended Schedule for Adults Released by ACIP
Major changes to the adult immunization schedule include new recommendations for the recombinant zoster vaccine and additional doses of the MMR vaccine in a mumps outbreak setting.
FDA: New Drug Application for Oral Drug Candidate for Major Depressive Disorder
ALKS 5461 (buprenorphine/samidorphan) is an oral drug candidate for the adjunct treatment of major depressive disorder.
-
Loading...
-
Loading...
Next post in Medicine
